219 related articles for article (PubMed ID: 9191126)
1. Regulation of apoptosis through CD95 (APO-I/Fas) receptor-ligand interaction.
Debatin KM; Beltinger C; Böhler T; Fellenberg J; Friesen C; Fulda S; Herr I; Los M; Scheuerpflug C; Sieverts H; Stahnke K
Biochem Soc Trans; 1997 May; 25(2):405-10. PubMed ID: 9191126
[No Abstract] [Full Text] [Related]
2. Early work on the function of CD95, an interview with Shige Nagata.
Nagata S
Cell Death Differ; 2004 Jul; 11 Suppl 1():S23-7. PubMed ID: 15143352
[No Abstract] [Full Text] [Related]
3. The CD95(APO-1/Fas)/CD95L system.
Krammer PH
Toxicol Lett; 1998 Dec; 102-103():131-7. PubMed ID: 10022244
[TBL] [Abstract][Full Text] [Related]
4. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
5. Cell death in T- and B-cell development.
Debatin KM
Ann Hematol; 2001; 80 Suppl 3():B29-31. PubMed ID: 11757701
[No Abstract] [Full Text] [Related]
6. Mutations in apoptosis genes: a pathogenetic factor for human disease.
Müllauer L; Gruber P; Sebinger D; Buch J; Wohlfart S; Chott A
Mutat Res; 2001 Jul; 488(3):211-31. PubMed ID: 11397650
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis by death factor.
Nagata S
Cell; 1997 Feb; 88(3):355-65. PubMed ID: 9039262
[No Abstract] [Full Text] [Related]
8. TNF receptor 2-deficient CD8 T cells are resistant to Fas/Fas ligand-induced cell death.
Teh HS; Seebaran A; Teh SJ
J Immunol; 2000 Nov; 165(9):4814-21. PubMed ID: 11046004
[TBL] [Abstract][Full Text] [Related]
9. Mature T lymphocyte apoptosis in the healthy and diseased immune system.
Zheng L; Fisher G; Combadiere B; Hornung F; Martin D; Pelfrey C; Wang J; Lenardo M
Adv Exp Med Biol; 1996; 406():229-39. PubMed ID: 8910689
[No Abstract] [Full Text] [Related]
10. Termination of antigen-specific immunity by CD95 ligand (Fas ligand) and IL-10.
Barreiro R; Luker G; Herndon J; Ferguson TA
J Immunol; 2004 Aug; 173(3):1519-25. PubMed ID: 15265879
[TBL] [Abstract][Full Text] [Related]
11. Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder.
Kasahara Y; Wada T; Niida Y; Yachie A; Seki H; Ishida Y; Sakai T; Koizumi F; Koizumi S; Miyawaki T; Taniguchi N
Int Immunol; 1998 Feb; 10(2):195-202. PubMed ID: 9533447
[TBL] [Abstract][Full Text] [Related]
12. CD95(APO-1/Fas)-mediated apoptosis: live and let die.
Krammer PH
Adv Immunol; 1999; 71():163-210. PubMed ID: 9917913
[No Abstract] [Full Text] [Related]
13. The Fas counterattack: cancer as a site of immune privilege.
O'Connell J; Bennett MW; O'Sullivan GC; Collins JK; Shanahan F
Immunol Today; 1999 Jan; 20(1):46-52. PubMed ID: 10081230
[No Abstract] [Full Text] [Related]
14. The Fas death factor.
Nagata S; Golstein P
Science; 1995 Mar; 267(5203):1449-56. PubMed ID: 7533326
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of APO-1/Fas(CD95)-mediated apoptosis in tolerance and AIDS.
Dhein J; Walczak H; Westendorp MO; Bäumler C; Stricker K; Frank R; Debatin KM; Krammer PH
Behring Inst Mitt; 1995 Jun; (96):13-20. PubMed ID: 7575348
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis by cancer chemotherapy.
Kaufmann SH; Earnshaw WC
Exp Cell Res; 2000 Apr; 256(1):42-9. PubMed ID: 10739650
[TBL] [Abstract][Full Text] [Related]
17. Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis.
Cascino I; Papoff G; De Maria R; Testi R; Ruberti G
J Immunol; 1996 Jan; 156(1):13-7. PubMed ID: 8598453
[TBL] [Abstract][Full Text] [Related]
18. CD95 (APO-1/Fas) in hematopoietic diseases.
Debatin KM
Results Probl Cell Differ; 1998; 24():157-74. PubMed ID: 9949836
[No Abstract] [Full Text] [Related]
19. Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils.
Luttmann W; Opfer A; Dauer E; Foerster M; Matthys H; Eibel H; Schulze-Osthoff K; Kroegel C; Virchow JC
Eur J Immunol; 1998 Jul; 28(7):2057-65. PubMed ID: 9692873
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune disease results from multiple interactive defects in apoptosis induction molecules and signaling pathways.
Mountz JD; Zhou T; Su X; Cheng J; Pierson M; Bluethmann H; Edwards CK
Behring Inst Mitt; 1996 Oct; (97):200-19. PubMed ID: 8950477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
